3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Sarcopenia
1
Prediabetic State
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid
1
Hematologic Neoplasms
1
Anemia, Aplastic
1
Interventions
Cyclophosphamide
8
Whole-Body Irradiation
7
fludarabine phosphate
6
Peripheral Blood Stem Cell Transplantation
5
Mycophenolic Acid
5
fludarabine
4
Tacrolimus
4
Melphalan
4
Busulfan
4
Stem Cell Transplantation
2
Sirolimus
2
nicotinamide-beta-riboside
1
methanesulfonic acid
1
daratumumab
1
X-Rays
1
Valganciclovir
1
Transplantation
1
Therapeutics
1
Specimen Handling
1
Radiotherapy
1
Polymerase Chain Reaction
1
Passive Cutaneous Anaphylaxis
1
Morphine
1
Methotrexate
1
Methadone
1
Mesna
1
Influenza Vaccines
1
Hydromorphone
1
Honey
1
Hematopoietic Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
nicotinamide-beta-riboside
×
1 year
×
Clear all
NCT05194397
2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2
Recruiting
80 enrolled